Technical Analysis for IMNM - Immunome, Inc.

Grade Last Price % Change Price Change
C 22.10 -1.69% -0.38
IMNM closed down 1.69 percent on Monday, March 18, 2024, on 45 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 21
*** please verify all earnings dates ***
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Oversold Stochastic Weakness -1.69%
1,2,3 Pullback Bullish Bullish Swing Setup -1.52%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.52%
Oversold Stochastic Weakness -1.52%
20 DMA Resistance Bearish -6.75%
Stochastic Reached Oversold Weakness -6.75%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 17 hours ago
Down 2 % about 20 hours ago
Down 1% about 20 hours ago
Up 2% about 20 hours ago
Up 1% about 20 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against universal cancer antigens. Its RealMAb technology enables the discovery of novel antigens and the cognate native human antibodies that target antigens; and ScreenMab multiplex functional screening technology identifies monoclonal antibodies that have exquisite for tumor neoantigens. The company was founded in 2006 and is based in Exton, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Immunology Immune System Antibodies Tumor Cancer Immunotherapy Monoclonal Antibodies Monoclonal Antibody Antibody Glycoproteins Antigen Symphogen

Is IMNM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Comments

T

TraderMike about 1 month ago

I was in the right place at the right time on this today. 🎉  I actually bought it yesterday after it made a (you guessed it) 
Non-ADX 1,2,3,4 Bullish
 signal the day before.  I sold half around 21 and am still holding the other half of the shares.  

0 Reply

View full discussion...

Indicators

Indicator Value
52 Week High 30.958
52 Week Low 4.44
Average Volume 738,548
200-Day Moving Average 10.72
50-Day Moving Average 20.15
20-Day Moving Average 24.29
10-Day Moving Average 24.42
Average True Range 2.02
RSI (14) 46.81
ADX 41.91
+DI 26.70
-DI 20.45
Chandelier Exit (Long, 3 ATRs) 24.90
Chandelier Exit (Short, 3 ATRs) 27.32
Upper Bollinger Bands 27.29
Lower Bollinger Band 21.28
Percent B (%b) 0.14
BandWidth 24.75
MACD Line 0.72
MACD Signal Line 1.45
MACD Histogram -0.7298
Fundamentals Value
Market Cap 995.13 Million
Num Shares 45 Million
EPS -1.80
Price-to-Earnings (P/E) Ratio -12.28
Price-to-Sales 105.68
Price-to-Book 174.08
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.79
Resistance 3 (R3) 23.88 23.41 23.51
Resistance 2 (R2) 23.41 22.98 23.36 23.41
Resistance 1 (R1) 22.76 22.71 22.52 22.66 23.32
Pivot Point 22.29 22.29 22.17 22.24 22.29
Support 1 (S1) 21.63 21.86 21.40 21.54 20.88
Support 2 (S2) 21.16 21.59 21.11 20.79
Support 3 (S3) 20.51 21.16 20.69
Support 4 (S4) 20.41